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The MAPKKK dual leucine zipper-containing kinase (DLK, Wallenda in Drosophila) is an evolutionarily conserved component of the
axonal injury responsepathway.After nerve injury,DLKpromotes degenerationof distal axons and regenerationof proximal axons. This
dual role in coordinating degeneration and regeneration suggests that DLK may be a sensor of axon injury, and so understanding how
DLK is activated is important. Twomechanisms are known to activate DLK. First, increasing the levels of DLK via overexpression or loss
of thePHRubiquitin ligases that targetDLKactivateDLKsignaling. Second, inCaenorhabditis elegans, a calcium-dependentmechanism,
can activate DLK. Here we describe a new mechanism that activates DLK in Drosophila: loss of the spectraplakin short stop (shot). In a
genetic screen for mutants with defective neuromuscular junction development, we identify a hypomorphic allele of shot that displays
synaptic terminal overgrowth and a precocious regenerative response to nerve injury. We demonstrate that both phenotypes are the
result of overactivationof theDLKsignalingpathway.We further show that, unlikemutations in thePHR ligaseHighwire, loss of function
of shot activates DLKwithout a concomitant increase in the levels of DLK. As a spectraplakin, Shot binds to both actin andmicrotubules
and promotes cytoskeletal stability. The DLK pathway is also activated by downregulation of the TCP1 chaperonin complex, whose
normal function is to promote cytoskeletal stability. These findings support the model that DLK is activated by cytoskeletal instability,
which is a shared feature of both spectraplakin mutants and injured axons.
Introduction
A conserved signaling pathway featuring the PHR ubiquitin li-
gase and its target, the MAPKKK DLK, regulates both neural
circuit development and the axon injury response pathway (Tian
and Wu, 2013). In Drosophila, loss of the PHR ligase Highwire
leads to a dramatic expansion of the neuromuscular junction
(NMJ) (Wan et al., 2000; DiAntonio et al., 2001) and promotes
both proximal axon regeneration and distal axon degeneration in
response to nerve injury (Xiong et al., 2010, 2012). The PHR
ligase is conserved in worms and mice, where it also regulates
circuit development (Schaefer et al., 2000; Zhen et al., 2000;
Bloom et al., 2007; Lewcock et al., 2007; Culican et al., 2009) and
the response to nerve injury (Nix et al., 2011; Babetto et al., 2013).
The Highwire ligase targets theMAPKKKWallenda/DLK, and in
highwiremutants the levels of Wallenda/DLK rise and the down-
stream JNK/Fos pathway is overactivated (Collins et al., 2006). A
series of recent studies demonstrate that DLK is a central compo-
nent of an evolutionarily conserved axon injury response path-
way, regulating both axon regeneration (Hammarlund et al.,
2009; Yan et al., 2009; Xiong et al., 2010; Shin et al., 2012) and
axon degeneration (Miller et al., 2009; Xiong and Collins, 2012).
Despite the clear importance of DLK after nerve injury, our un-
derstanding of how DLK/Wallenda is activated in vivo is limited.
To date, twomethods for activatingDLKhave been described.
First, DLK is activated when its levels rise because of transgenic
overexpression, loss of the PHR ligase, or JNK activation (Nakata
et al., 2005; Collins et al., 2006; Huntwork-Rodriguez et al.,
2013). Second, in Caenorhabditis elegans, an elegant Ca2-
dependent mechanism activates the DLK ortholog DLK-1 (Yan
and Jin, 2012). Mammalian and Drosophila DLK, however, lack
the hexapeptide sequence that mediates this form of regulation,
suggesting that additional DLK activation mechanisms exist.
In this study, we demonstrate that the Drosophila spectra-
plakin short stop (shot) inhibits the activation of Wallenda/DLK.
Spectraplakins are largemultidomain proteins that cross-link ac-
tin andmicrotubules to regulate cytoskeletal dynamics (Suozzi et
al., 2012). Previously described shot alleles are embryonic lethal,
have disrupted microtubule dynamics, and exhibit severe defects
in axon outgrowth (Lee and Kolodziej, 2002; Bottenberg et al.,
2009; Alves-Silva et al., 2012). Here we identify a viable loss-of-
function allele of shot that displays dramatic synaptic terminal
overgrowth at the NMJ. In this mutant, theWallenda/DLK path-
way is overactivated leading to both NMJ overgrowth and en-
hanced response to axonal injury, yet unlike in highwiremutants,
the levels of Wallenda/DLK are not elevated. These observations
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suggest a model in which tonic cytoskeletal destabilization in the
shot mutant activates Wallenda/DLK without altering its levels.
In support of this model, mutations in the TCP1 chaperonin
complex, which is also required for stability of the tubulin and
actin cytoskeleton (Ursic et al., 1994; Grantham et al., 2006), also
activate DLK signaling. These findings led us to speculate that
axonal injury activates DLK via acute cytoskeletal destabilization.
Materials andMethods
Fly stocks. Flies were maintained at 25°C on standard fly food. We used
the following fly stocks in our studies: Canton S (WT), elav-Gal4 (Yao
and White, 1994), 24B-Gal4 (Brand and Perrimon, 1993), BG380-Gal4
(Sanyal, 2009), m12-Gal4 (P(GAL4)5053A) (Klapper, 2000), wnd2 and
wnd3 (Collins et al., 2006), UAS-bskDN (Weber et al., 2000), UAS-
fosDN(Fbz) (Eresh et al., 1997), and puc-LacZ (Martín-Blanco et al.,
1998). The following fly lines were obtained from the Bloomington Stock
Center: shot3 (Kolodziej et al., 1995), the deficiency line Df(2R)BSC383,
shot RNAi line P{TRiP.GL01286}attP2, TCP1 and TCP1 RNAi lines,
shot rescue constructsUAS-shot L(A)-GFP (shot-FL in this paper),UAS-
shot L(C)-GFP (shot-Calponin in this paper), UAS-shot L(A)-DeltaEF-
hand-GFP (shot-EF ),UAS-shot L(A)-DeltaPlakin-GFP (Shot-Plakin),
UAS-shot L(A)-Deltarod1-GFP (shot-Rod) (Bottenberg et al., 2009),
UAS-EB1-GFP, and ppk-Gal4. UAS-shot L(A)-DeltaGAS2-GFP (shot 
Gas2) was obtained from Andreas Prokop.UAS-wnd RNAi and RNAis
against neuroligin and CG18278 were obtained from Vienna RNAi stock
center (Dietzl et al., 2007).
Immunohistochemistry. Third-instar larvae were dissected in PBS and
fixed in either Bouin’s fixative for 5 min or 4% formaldehyde for 20 min
on ice. Larvae were washed with PBS containing 0.1% Triton X-100
(PBT) and blocked in 5%NGS in PBT for 30 min, followed by overnight
incubation in primary antibodies in 5% NGS in PBT, three washes in
PBT, incubation in secondary antibodies in 5% NGS in PBT for 45 min,
three final washes in PBT, and equilibration in 70% glycerol in PBS.
Samples were mounted in VectaShield (Vector). The following primary
antibodies were used: mouse -Brp, 1:500 (Developmental Studies Hy-
bridoma Bank), mouse -Dlg monoclonal antibody (mAb) 4f3, 1:2000
(Developmental Studies Hybridoma Bank), rabbit -DGluRIII, 1:2500
(Marrus et al., 2004), rabbit -DVGLUT, 1:10,000 (Daniels et al., 2004),
rat anti-Elav, 1:50 (7E8A10; Developmental Studies Hybridoma Bank),
mouse anti-LacZ, 1:100 (40-1a; Developmental Studies Hybridoma
Bank), rabbit -Wallenda (Collins et al., 2006), and A488 rabbit anti-
GFP, 1:1000 (Invitrogen). Goat Cy5-, Cy3-, and FITC-conjugated sec-
ondary antibodies against mouse and rabbit IgG were used at 1:1000 and
were obtained from Jackson ImmunoResearch Laboratories. Antibodies
obtained from the Developmental Studies Hybridoma Bank were devel-
oped under the auspices of the National Institute of Child Health and
Human Development and maintained by the Department of Biological
Sciences of the University of Iowa, Iowa City, Iowa.
Western blot. Third-instar larval brains were homogenized in ice-cold
homogenization buffer (67 mM Tris-HCl, pH 8.0, 67 mMNaCl, 2 M urea,
1 mM EDTA, and 1.3% SDS), and samples were run on 15% SDS-PAGE
gels according to standard procedures (Wu et al., 2005). Rabbit
-Wallenda was used at 1:100. Mouse -Armadillo (Developmental
Studies Hybridoma Bank) was used at 1:20. HRP-conjugated goat
-rabbit and -mouse (Jackson ImmunoResearch Laboratories) were
used at 1:10,000.
Imaging and analysis. Samples were imaged using a Nikon C1 confocal
microscope using 40 (for VNC images) or 60 (for NMJs) objectives.
All genotypes for an individual experiment were imaged at the same gain
and set such that signals from the brightest genotype for a given experi-
mentwere not saturating. Bothmale and female larvaewere used for each
experiment. To quantify the mean intensity of puc-lacZ expression, the
nuclei along the dorsalmidline of the ventral nerve cordswere selected by
the staining for Elav. puc-lacZ is localized to the nuclei in those cells
because of the NLS sequence fusion. The nuclei from at least 9 animals
per genotype were measured and then normalized to control. To quan-
tify Wallenda intensity in the neuropil of larval VNCs, the region was
selected based on the BRP staining. At least eight larvae were used per
genotype and the staining intensity was normalized to WT. Statistical
analysis was performed and graphs were generated using Origin 7.0
(Origin Laboratory). ANOVA was used for comparison of samples
within an experimental group. All histograms and measurements are
shown as mean SEM.
Live imaging.Wandering third-instar larvae were mounted on a slide
between a sylgard cushion and a coverslip, which was held in place with
orthodontic rubber bands. Live imaging was performed on a Quorum
spinning disc confocal/ 1X8-1-Olympus inverted microscope equipped
with a Hamamatsu 69100-13 camera and MetaMorph acquisition soft-
ware. Time-lapse movies were taken at one frame per 2 s using a 40 air
objective (NA 0.75). Analysis of microtubule dynamics was modified
from Chen et al. (2012). Briefly, the number of EB1 comets was counted
within 50mdendritic segments beginning 10m from the cell body of
multidendritic sensory neurons. Quantification was based on three con-
secutive in-focus frames. RNAi againstCG18278was used as a control. At
least two dendritic segments were averaged for each cell, blinded to ge-
notype. ImageJ software was used for image analysis.
Nerve crush assay and analysis. Larvae were positioned on their trachea
with the ventral nerves closest to the top surface, and then segmental
nerves were pinched tightly through the cuticle for 10 s with Dumostar
number 5 forceps. Larvae were transferred to a grape plate with inacti-
vated yeast and water mixture and kept alive for 7 h at 23°C. Pinched
larvae were then dissected and stained for the growth cone analysis,
which was modified from Xiong et al. (2010). Stained crushed proximal
stumps were analyzed for the presence of a growth cone while blinded to
the genotype. To score a growth cone as sprouting, the axons must have
at least five visible sprouts. Then, all analyzed crushed axons were com-
bined for each genotype, and the fraction of sprouting stumps was gen-
erated. At least 12 larvae with a minimum of 55 nerves were analyzed for
each genotype.  2 test was performed to assess statistically significant
differences among the genotypes.
Results
Short stop is required for normal synaptic terminal growth at
the larval NMJ
To identify novel regulators of synaptic development, we con-
ducted an anatomical screen on a subset of EMS mutants prese-
lected for adult lethality or abnormalities in larval or adult
locomotion. Third-instar larvae were dissected and stained with
antibodies against the active zone component Bruchpilot (Wagh
et al., 2006) and the essential glutamate receptor subunit DG-
luRIII (Marrus et al., 2004). We assessed various aspects of syn-
aptic development, including the apposition of presynaptic active
zones and postsynaptic glutamate receptor clusters, synaptic ter-
minal overgrowth and undergrowth, and synaptic maintenance
(Valakh et al., 2012). We focus here on a mutant that displayed
dramatic NMJ overgrowth. The phenotype is apparent when vi-
sualizing terminal morphology by staining for the postsynaptic
scaffolding protein Discs-large, the synaptic vesicle protein
DVGLUT, and the presynaptic membrane as visualized by an
antibody to HRP (Fig. 1A). Although the NMJ overgrowth is
present at the synapse on every muscle, the number of synaptic
boutons was quantified at the well-characterizedmuscle 4 type Ib
NMJ. Mutant NMJs contain approximately twice as many bou-
tons as in wild-type (WT) (Fig. 1A,C). To identify the gene re-
sponsible for the synaptic phenotype, we performed meiotic
recombination and deficiency mapping and identified a small
region in the second chromosome (50C6–50D2) that contains 34
genes.We then took a candidate approach, focusing on short stop
(shot), a large gene in the region with a known function in neu-
rons. The well-characterized null allele of shot, shot3 (Ro¨per and
Brown, 2003), failed to complement our new mutant, demon-
strating that it is a new allele of shot. We name this new allele
shotVV. Because shotVV is viable as a third-instar larvae, while all
previously described alleles of shot are embryonic lethal, this new
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allele is likely a hypomorph. However, the NMJ overgrowth phe-
notype of shotVV/shot3 is only slightly stronger than that of shotVV
alone (Fig. 1A,C), suggesting that the shotVV allele is a relatively
strong loss-of-function mutant, at least for its role in regulating
NMJ terminal growth. We use the combination of shotVV/shot3
for all subsequent experiments to avoid issues of second site mu-
tations, and we will refer to this genotype as shot.
To test whether the synaptic overgrowth phenotype of shot is
due to the absence of WT shot, we used the UAS/Gal4 system to
express transgenic Shot in a tissue-specificmanner. Expression of
a full-length long isoform Shot-FL (Bottenberg et al., 2009) with
the neuronal driver elav-Gal4 in the shotVV/shot3 mutant back-
ground rescues the synaptic terminal overgrowth (Fig. 1A,C). In
contrast,muscle expression of the same transgenewith the strong
muscle driver 24B-Gal4 was unable to rescue the phenotype.
Hence, the NMJ overgrowth results from the loss of shot function
and shot is required in neurons for normal synaptic development.
Because the nature of the mutation in shotVV allele is un-
known, we wanted to test whether loss of function of shot is
sufficient to induce the overgrowth phenotype. Driving a trans-
genic RNAi targeting shot with the neuronal driver elav-Gal4
leads to an expansion of the NMJ that is very similar to that of the
genetic mutant (Fig. 1B). Knockdown of shot in the muscle does
not result in a synaptic phenotype (Fig. 1B,D). These data indi-
cate that loss of function of shot in the nervous system is sufficient
to cause synaptic overgrowth.
The Rod and Plakin domains are dispensable for the function
of Shot in restraining NMJ growth
Spectraplakins are comprised of an N-terminal Calponin do-
main, a Plakin domain, a long rod domainwithmultiple Spectrin
repeats, and a C-terminal EF hand and mictrotubule-binding
growth arrest-specific 2 (Gas2) domain (Ro¨per et al., 2002). Spec-
traplakins perform different functions in different tissues, and
domains that are crucial in one context may be dispensable in
another (Bottenberg et al., 2009). To investigate the structural
requirements of Shot for NMJ growth, we used a series of trans-
genes that expresses GFP-tagged shot mutants that were previ-
ously generated lacking individual domains (Lee and Kolodziej,
2002, Bottenberg et al., 2009); the structures of the transgenes are
schematized in Figure 2A. For each deletion variant, we tested for
transport of GFP-Shot out of the cell bodies and into the axons as
well as genetic rescue of the shotNMJ overgrowth phenotype.We
find that the full-length Shot, Shot-FL, is abundant in axons. We
see similar axonal localization of Shot-Calponin, which lacks
one actin-binding Calponin homology domain, Shot-Rod,
lacking the large Spectrin repeat rod domain, and Shot-Plakin,
which lacks the large Plakin domain (Fig. 2B). However Shot-
EF, in which the Ca2 binding EF hand domain is deleted, and
Shot-Gas2, in which the microtubule-binding Gas2 domain is
deleted, show very little axonal accumulation (Fig. 2B). Shot-EF
shows strong expression in cell bodies (data not shown), suggest-
ing that this calcium-binding EF hand domain may be required
for efficient transport of Shot into the axon.
Figure 1. Synaptic terminal overgrowth at the NMJs in the shotmutant. A, Sample confocal images of muscle 4 type Ib NMJs of WT, shotvv/shotvv (shotvv), shotvv/shot3 and UAS-shot-FL-GFP/
shotvv/shot3; elav-Gal4/ (shotvv/shot3 rescue) stained for the postsynaptic DLG (red), presynaptic DVGLUT (green), and themembranemarker HRP (blue). Scale bar, 50m.B, Sample confocal
images of muscle 4 type Ib NMJs of UAS-dcr2, elav-Gal4/UAS-shot-RNAi (Neuronal shot RNAi), and UAS-dcr2; G7-Gal4/; UAS-shot-RNAi/ (Muscle shot RNAi). Muscle 4 type Ib bouton number of
the genotypes listed in A are quantified in C. **p 0.001, compared with WT. *p 0.05, compared with WT. Phenotypes listed in B with addition of UAS-dcr2;; elav-Gal4/ (control) were
quantified in D. **p 0.001, compared with control. n 15 for each genotype. Error bars indicate SEM.
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Having assessed the localization of these Shot deletion vari-
ants, we next tested whether expression of the transgene could
rescue the NMJ overgrowth phenotype of the shot mutant. Ex-
pression of the full-length Shot-FL rescues the mutant, and over-
expression of this transgene in a WT background does not affect
NMJ growth (Figs. 1A and 2C). We also observe robust rescue
with Shot-Plakin and Shot-Rod (Fig. 2C). Hence, the large
Plakin and rod domains, which are thought to serve as spacers
between the actin and microtubule binding domains, are dis-
pensable for the function of Shot in NMJ growth control. In
contrast, expression of Shot-Calponin is unable to rescue the
mutant phenotype. Because this protein is present in axons at
levels similar to that of the Shot-Plakin and Shot-Rod pro-
teins, the failure to rescue likely indicates that the absence of the
Calponin homology domain in this mutant abrogates its ability
to restrain synaptic terminal growth. Finally, neither the Shot-
EFnor the Shot-Gas2 rescues themutant phenotype (Fig. 2C).
Hence, this formally demonstrates that those domains are re-
quired for function, but thismay be the result of defects in axonal
localization, protein function, or both. Together, this structure
function analysis demonstrates that the various binding domains
at the N- and C-terminus of Shot are important for its ability to
restrain synaptic growth but that the spacing between those do-
mains is not.
Shot-dependent synaptic terminal overgrowth requires
Wallenda signaling
We wished to understand the molecular mechanism by which
shot restrains NMJ growth during development. The overgrowth
in shot is reminiscent of highwire mutants where absence of the
Figure2. Rescue constructsmissing theRoddomainandPlakindomain rescue theNMJovergrowthphenotypeof shot.A, Schematic representationof Short Stopand thedeletion constructs. Shot
Calponin is a Shot C isoform, which lacks one of the two Calponin homology domains. The rest of the constructs were derived from Shot A isoform represented in A as Shot FL (full-length). All
constructs are COOHGFP-tagged.B, Sample confocal images of twonerves in the larvae expressing deletion constructswith the strongneuronal driverBG380-Gal4 in theWTbackground. The nerves
are stained for GFP (green) to label the expression of the constructs and HRP (red) to label the neuronal membrane. Scale bar, 50m. C, Quantification of the muscle 4 type Ib bouton number in
elav-Gal4/ (Control), UAS-shot-FL/; elav-Gal4/ (shot FL o/e), shotvv/shot3; elav-Gal4/ (shot), UAS-shot-FL; shotvv/shot3; elav-Gal4/ (shot Shot FL), shotvv/shot3, UAS-shot-
Calponin; elav-Gal4/ (shot  Calponin), UAS-shot-Gas2/; shotvv/shot3; elav-Gal4/ (shot  Gas2), shotvv/shot3, UAS-shot-EFHand; elav-Gal4/ (shot  EF);
shotvv/shot3, UAS-shot-Rod1; elav-Gal4/ (shotRod), shotvv/shot3, UAS-shot-Plakin; elav-Gal4/ (shotPlakin). **p 0.001, compared with shotvv/shot3; elav-Gal4/
(shot). n 15 for each genotype. Error bars indicate SEM.
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ubiquitin ligase Highwire leads to an increase in the levels of the
MAPKKK Wallenda/DLK and subsequently increased down-
stream JNK/Fos signaling. Hence, we tested whether wallenda is
necessary for the synaptic overgrowth phenotype of shot. Remov-
ing one copy of wallenda significantly suppresses the NMJ phe-
notype in shot mutants (Fig. 3A,B). Loss of both copies of
wallenda in the shot mutant background (shotVV/shot3; wnd2/
wnd3) results in full suppression (Fig. 3A,B). Hence, wallenda is
required for shot-dependent synaptic terminal overgrowth, and
the degree of overgrowth depends on the dose ofWallenda/DLK,
suggesting that the extent of DLK activity is instructive for syn-
aptic terminal overgrowth.
In the highwiremutant,wallenda-dependentNMJovergrowth
requires the downstreamMAPkinase JNK as well as its target, the
transcription factor Fos. To investigate the role of JNK and Fos
for the shot phenotype, we used the same dominant-negative
constructs used for the analysis of highwire (Collins et al., 2006).
Expression of a dominant-negative transgene of either JNK or fos
in neurons suppresses the increase in synaptic bouton number
in the shot mutant (Fig. 3A,C). Hence, shot-dependent NMJ
overgrowth requires the same signaling pathway as highwire-
dependent overgrowth, the MAP3K Wallenda/DLK, the
MAPK JNK, and the transcription factor Fos.
Shot does not regulateWallenda protein levels
In highwire mutants, absence of the ubiquitin ligase Highwire
leads to an increase in the levels of Wallenda/DLK, which then
activates the JNK/Fos pathway. Overex-
pression of Wallenda/DLK can also en-
gage the JNK/Fos pathway to trigger NMJ
overgrowth (Collins et al., 2006). Hence,
increasing the levels of theWallenda/DLK
can overactivate this pathway, and this is
the only known mechanism to activate
Wallenda/DLK signaling in Drosophila.
Because the shot phenotype also re-
quires the Wallenda/DLK pathway, we
wondered whether Shot also regulates the
abundance of Wallenda/DLK. We used a
previously generated and validated anti-
body (Collins et al., 2006) to assess the
levels ofWallenda inwhole-brain homog-
enates via Western blot. In WT larvae,
Wallenda levels are very low; and as pre-
viously described, they are significantly
increased in the highwiremutant. In con-
trast, in shotmutant larvaeWallenda pro-
tein levels are similar to those observed in
WT (Fig. 4A,B). Similar results were
obtained using immunohistochemistry:
Wallenda protein is enriched in the syn-
aptic neuropil of the highwiremutant but
is at WT levels in the shot mutant (Fig.
4C,D). Hence, although the Wallenda
pathway is required for synaptic over-
growth in shot, the levels ofWallenda pro-
tein, unlike in highwire mutant, are not
increased. Hence, shot does not function
by controlling Wallenda levels.
Shot inhibits Wallenda/DLK
pathway activity
The requirement of the Wallenda path-
way for shot-dependent synaptic overgrowth is consistent with at
least twomodels. First, theWallenda pathwaymay play a permis-
sive role in shot-dependent synaptic overgrowth. Here Wallenda
would be necessary, but shotwould function in an alternate path-
way. Alternatively, Shotmay act by inhibiting theWallenda path-
way activity. In this model, the Wallenda pathway would be
upregulated in the shotmutant. To distinguish between these two
possibilities, we probed JNK pathway activity in the shotmutant.
JNK pathway activity can be assayed in Drosophila via a LacZ
enhancer trap that is inserted into the JNK phosphatase puckered
(Martín-Blanco et al., 1998), which is a transcriptional target of
the JNK pathway. puc-LacZ is expressed at low levels in larval
neurons from WT flies and is elevated when the Wallenda/DLK
pathway is overactivated in highwiremutants (Xiong et al., 2010).
We quantified the levels of puc-LacZ expression in neurons from
both WT and shot mutant larvae. The level of puc-LacZ expres-
sion is increased approximately threefold over WT in shot (Fig.
5A,B), demonstrating that the JNKpathway is upregulated in the
shotmutant.
Because the JNK pathway can be upregulated by a variety of
upstream kinases (Davis, 2000), we tested whether Wallenda is
necessary for activation of the JNK pathway. As previously de-
scribed (Xiong et al., 2010), we were unable to generate recom-
binants between wallenda and puc-LacZ. Instead, we tested the
role of Wallenda/DLK using a previously verified RNAi line
(Xiong et al., 2010). Knockdown of shot expression using RNAi
recapitulates the NMJ overgrowth phenotype (Fig. 1B) and also
Figure 3. wallenda (DLK) mutation and its downstream factors suppress the NMJ overgrowth in shot. A, Sample confocal
images of muscle 4 type Ib NMJs of shotvv/shot3; elav-Gal4/ (shot), shotvv/shot3; wnd2/ (shot; wnd/), shotvv/shot3; wnd2/
wnd3 (shot;wnd), shotvv/shot3; elav-Gal4/UAS-bskDN (shot Jnk DN), shotvv/shot3; elav-Gal4/UAS-fbz (shot Fos DN). B, Quanti-
fication of the muscle 4 type Ib bouton number in WT, shotvv/shot3 (shot), and shotvv/shot3; wnd2/wnd3 (shot; wnd). C,
Quantification of the muscle 4 type Ib bouton number in elav-Gal4/ (control) and the lower two genotypes in A. **p 0.001,
compared with WT or control. n 15 for each genotype. Scale bar, 50m.
Valakh et al. • Loss of Short Stop Activates DLK Injury Pathway J. Neurosci., November 6, 2013 • 33(45):17863–17873 • 17867
leads to increased expression of puc-lacZ as in the classical mu-
tant (Fig. 5). Double knockdown of shot andwallenda suppresses
this increase in puc-lacZ expression (Fig. 5A,C). The suppression
of puc-lacZ expression with wallenda RNAi is not the result of
dilution of Gal4 activity in the presence of multiple UAS lines
because we failed to find suppression with two control UAS-
RNAi constructs (shot RNAi, 3.0  0.1 a.u.; shot RNAi 
CG13772 RNAi, 3.2  0.1 a.u; shot RNAi  CG18278 RNAi,
3.6 0.2 a.u.). Together, these data demonstrate that in the shot
mutant theWallenda/DLK signaling pathway is upregulated; and
so when Shot function is unperturbed, the Wallenda/DLK path-
way is inhibited. Because Shot does not function by controlling
the levels ofWallenda as Highwire does, Shot must function via a
novel mechanism to control the activation of Wallenda/DLK.
Cytoskeletal disruption and the activation of the
Wallenda/DLK pathway
Short Stop acts as an actin-microtubule cross-linker; and in shot
null embryos, the microtubule skeleton is less stable (Alves-Silva
et al., 2012). To explore the possibility that disrupting the cyto-
skeleton might activate Wallenda/DLK, we first tested whether
the inhibition of shot in larvae also destabilizes the cytoskeleton.
We assessed in vivomicrotubule dynamics by expressing the mi-
crotubule plus end binding-protein EB1-GFP in sensory neurons
with ppk-Gal4. EB1-GFP labels the growing ends ofmicrotubules
in structures called “comets,” the number of which reflect the
number of growing microtubules (Chen et al., 2012). Knock-
down of short stop results in an approximate doubling of comets
labeled with EB1 (control RNAi: 2.7  1.5 comets, n 	 21 neu-
rons; shot RNAi: 5.3 0.8 comets, n	 14 neurons; p	 0.001),
demonstrating that the microtubule network is more dynamic/
less stable (Fig. 6A). The role of short stop in stabilizing the cyto-
skeleton and in the activation of the Wallenda/DLK pathway in
shotmutants is consistent withmicrotubule destabilization being
the mechanism that activates Wallenda/DLK.
If cytoskeletal destabilization activates Wallenda/DLK activa-
tion, then other mutants that disrupt the cytoskeleton would be
predicted to activateWallenda/DLK. To this end, we targeted two
subunits of the T-complex protein-1 (TCP1) complex. TCP1 is a
cytosolic chaperone for tubulin and actin. Data from yeast and
Figure 4. Wallenda/DLK levels are not increased in shot mutant. A, Representative Western blots of extracts from larval brain and ventral nerve cords of WT, highwireC mutant (hiw), and
shotvv/shot3 (shot) probed forWallenda andArmadillo as a loading control.B, The levels of theprotein are quantified from three independentWesternblots and thennormalized to control fromeach
blot. *p 0.01, compared with WT. C, Staining for endogenous Wallenda in the ventral nerve cords of third-instar larvae for WT, highwireC mutant (highwire), and shotvv/shot3 (shot). The
Wallenda antibody is labeled in green, and the neuropil is labeled with synaptic marker BRP (red). The Wallenda intensity in the neuropil was measured for each genotype and normalized to WT
levels. D, The quantification is presented as mean SEM. **p 0.001, compared with WT. n 9 brains for each genotype. Scale bar, 50m.
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mammalian cell lines show that, when this complex is disrupted,
the microtubule network is destabilized (Ursic et al., 1994;
Grantham et al., 2006). We find that RNAi-mediated downregu-
lation of the genes for either TCP1 or TCP1, two required
subunits of the TCP1 complex, also activates the JNK pathway,
and this activation requires wallenda (Fig. 6B). Hence, this inde-
pendent manipulation recapitulates our findings with short stop
and is consistent with the model that the activation of the DLK/
Wallenda pathway in shot is the result of destabilization of the
cytoskeleton.
Shot mutants accelerate the regenerative response to injury
via theWallenda/DLK pathway
In addition to its role in synapse development, Wallenda/DLK
signaling also promotes axonal regeneration after injury in
worms, flies, andmammals (Hammarlund et al., 2009; Yan et al.,
2009; Xiong et al., 2010; Shin et al., 2012). In Drosophila, loss of
highwire leads to an increase in the levels of Wallenda/DLK that
speeds the regenerative response (Xiong et al., 2010). We won-
dered whether it would be possible to promote regenerative
sprouting by activating the Wallenda/DLK pathway without an
increase in Wallenda levels. shot mutants have normal levels of
Wallenda protein but increased pathway activity, so we tested
whether this activation is sufficient to hasten the regenerative
response to injury. We labeled two axons per nerve using m12-
Gal4 to drive expression of a membrane-tagged GFP, crushed
peripheral nerves as previously described (Xiong et al., 2010), and
assessed the regenerative potential of axons in Drosophila larvae.
To quantify the response, we counted the fraction of injured
nerves that show a large growth cone 7 h after crush (for details of
blinded analysis, see Materials and Methods). Seven hours after
injury,WT axons are just beginning to regenerate, with only 15%
showing the regenerative response of a sprouting growth cone.
On the other hand, in shot mutants 52% of axons have new ax-
onal sprouts (Fig. 7A,B). We next investigated whether the im-
proved regenerative response in shot requires wallenda. RNAi
knockdown of shot shows a very similar increase in the number of
regenerative sprouts as the classical shotmutant. However, when
combined with wallenda RNAi the enhanced regenerative re-
sponse is eliminated (Fig. 7C,D). These data demonstrate that the
Wallenda/DLK pathway is required for more rapid formation of
regenerative axonal branches in the absence of shot. Hence, loss of
shot improves the regenerative response to injury by activating
the Wallenda/DLK pathway.
Discussion
The MAPKKK Wallenda/DLK is an important regulator of syn-
aptic terminal development and the axonal response to injury
(Collins et al., 2006; Hammarlund et al., 2009; Xiong et al., 2010;
Shin et al., 2012). However, the mechanisms that activate this
kinase are not well understood. Here we show that mutation of
the spectraplakin Short stop leads to activation ofWallenda/DLK
signaling, resulting in synaptic terminal overgrowth and an ac-
celerated regenerative response to axonal injury.
A new function for the spectraplakin short stop
Spectraplakins are huge, multidomain proteins that bind to both
actin and microtubules to regulate cytoskeletal dynamics. The
family of spectraplakins consists of mammalian bpag1/dystonin
(Sawamura et al., 1991) and ACF7/MAC1 (Leung et al., 1999),
Drosophila short stop (shot)/kakapo (Gregory and Brown, 1998),
and C. elegans vab-10 (Suozzi et al., 2012). Spectraplakins func-
tion in many cellular processes, including regulating ER-Golgi
transport in mammalian sensory neurons (Ryan et al., 2012a,
2012b) and mediating polarized locomotion of skin stem cells
upon injury (Wu et al., 2011). They also play an essential role in
axons, asmutations inmammalian spectraplakins lead to periph-
eral neuropathy in both mice and humans (Bernier et al., 1995;
Edvardson et al., 2012). InDrosophila, the spectraplakin short stop
has been extensively studied for its role in embryonic axon out-
growth and its regulation of microtubule dynamics (Lee et al.,
2000; Sanchez-Soriano et al., 2009; Alves-Silva et al., 2012). All
Figure 5. puc-LacZ expression is increased in shot mutant ventral nerve cords in a wallenda-dependent manner. A, Larval ventral nerve cords of puc-LacZ/ (WT), shotvv/shot3;puc-LacZ /
(shot), elav-Gal4,UAS-dcr2/;UAS-shot-RNAi/puc-LacZ (shot RNAi), and elav-Gal4,UAS-dcr2/UAS-wnd-RNAi; UAS-shot-RNAi/puc-LacZ (shot RNAi; wnd RNAi) stained for puc-LacZ expression in
green (left) and Elav protein (red). puc-LacZ expression isweak in theWT ventral nerve cords but is increased in shotmutant and shotRNAi larvae. The levels of puc-LacZ are quantified in the neurons
along thedorsalmidline identified by Elav protein expression of thegenotypes fromA in addition to elav-Gal4,UAS-dcr2/;puc-LacZ/ (Control) are represented inB andC asmean SEM. **p
0.001, compared with WT or control (elav-Gal4, UAS-dcr2/). n 9 brains for each genotype. Scale bar, 50m.
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prior loss-of-function mutants in shot are embryonic lethal, and
these strong alleles have severe impairments of their cytoskeleton
and poor axon outgrowth, leading axons to “stop short” of their
targets (Lee et al., 2000). This embryonic phenotype is in appar-
ent contradiction to the larval phenotype we describe for the
shotVV allele, in which the synaptic terminal is overgrown with
additional synaptic boutons. However the shotVV allele is a hypo-
morph and motor axons successfully navigate to their targets, so
this mutant must retain sufficient function to allow for axonal
outgrowth. Although shotVV behaves as a hypomorph, themolec-
ular lesion was not identified, and so it is plausible that this allele
is a neomorph and that its regulation of DLK may not reflect the
normal function of the protein. However, we find that RNAi
knockdown of shot generates the same phentoypes as shotVV and
leads to the same activation of Wallenda/DLK. Hence, both the
shotVV allele and shot RNAi provide evidence for a new function
for shot, namely, as a negative regulator ofWallenda/DLK signal-
ing. It will be interesting to determine whether mammalian spec-
traplakins also restrain DLK signaling and whether dysregulated
MAP kinase pathways may mediate some of the phenotypes of
spectraplakin mutants, such as peripheral neuropathy.
Activation of Wallenda/DLK
A series of recent studies highlights the central role of DLK in the
developing and injured mammalian nervous system. DLK is re-
quired for normal developmental cell death inmotor and sensory
neurons (Ghosh et al., 2011; Itoh et al., 2011), for Wallerian
degeneration of injured peripheral axons (Miller et al., 2009), for
cell death and axon degeneration of retinal ganglion cells inmod-
els of glaucoma (Watkins et al., 2013, Welsbie et al., 2013), and
for the proregenerative preconditioning response in injured
DRG axons (Shin et al., 2012). Because DLK appears to be central
to the neuronal injury response, there is great interest in under-
standing its mechanism of activation. In particular, it is impor-
tant to understand how axon injury leads to the activation of
DLK.
To date, methods that increase the levels of DLK are the best
understood mechanism for increasing DLK activity. In worms,
flies, and mice, loss of the PHR ubiquitin ligase leads to an in-
crease in the levels ofDLK (Nakata et al., 2005; Collins et al., 2006;
Babetto et al., 2013); and in worms and flies, there are extensive
data demonstrating that this activates the kinase. Similarly, in
both worms and flies, the overexpression of DLK is sufficient to
Figure 6. Cytoskeletal disruption and the activation of theWallenda/DLK pathway.A, Growingmicrotubule plus-endsmarked by EB1-GFP expression driven by ppk-Gal4 in a branch of a sensory
neuron in UAS-dcr2/UAS-CG18287-RNAi; ppk-Gal4, UAS-EB1-GFP (Control RNAi) and UAS-dcr2/;UAS-shot-RNAi/ppk-Gal4, UAS-EB1-GFP (shot RNAi) larvae. Arrowheads indicatemoving EB1-GFP
comets, and asterisks indicate stationary puncta. Only the moving comets were counted in the area. Knockdown of shot expression results in approximate doubling of the growing microtubule
plus-ends compared with control. Scale bar, 10m. B, Larval ventral nerve cords of elav-Gal4,UAS-dcr2/;puc-LacZ/ (Control), elav-Gal4, UAS-dcr2/;UAS-TCP1-RNAi/puc-LacZ (TCP1-
RNAi), elav-Gal4, UAS-dcr2/;UAS-TCP1-RNAi/puc-LacZ (TCP1-RNAi), elav-Gal4, UAS-dcr2/UAS-wnd-RNAi;UAS-TCP1-RNAi/puc-LacZ (TCP1-RNAi;wndRNAi), elav-Gal4, UAS-dcr2/UAS-wnd-
RNAi; UAS-TCP1-RNAi/puc-LacZ (TCP1-RNAi; wnd RNAi), stained for puc-LacZ expression in green (left) and Elav protein (red). puc-LacZ expression is increased in TCP1 RNAi larvae. C, The levels
of puc-LacZ are quantified in the neurons along the dorsal midline identified by Elav protein expression are represented as mean SEM. **p 0.001, compared with WT. n 9 brains for each
genotype. Scale bar, 50m.
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activate the DLK signaling pathway. InDrosophila, injury leads to a
loss of the PHR ubiquitin ligase Highwire (Xiong et al., 2010), po-
tentially via autophagosomal degradation (Shen and Ganetzky,
2009;Tianetal., 2011),which in turn leads toan increase inDLKand
may be amethod of injury-induced activation. In mammals, a pos-
itive feedback loop betweenDLK and JNK inhibits Phr1-dependent
degradation of DLK, increasing the levels of DLK and activating the
pathway (Huntwork-Rodriguez et al., 2013). In addition, a calcium-
dependent activation mechanism was recently demonstrated in C.
elegans (Yan and Jin, 2012), which is very exciting because calcium
influx is an early step after axon injury. However, the key hexapep-
tide sequence that mediates this calcium-dependent regulation is
absent from bothDrosophila andmouseDLK, suggesting that addi-
tional activation mechanisms for DLK may exist. Indeed, our data
show that loss of the spectraplakin shot can also activate DLK and
leads to the hypothesis that cytoskeletal disruptions may activate
DLK.Our findings demonstrate that loss of function of shot leads to
activation of Wallenda/DLK without a concomitant increase in the
levels ofWallenda/DLK.Hence, loss of shot is not actingupstreamor
inconcertwithHighwirebecause lossofHighwireor componentsof
the Highwire ubiquitin ligase complex lead to increased levels of
Wallenda/DLK (Collins et al., 2006; Wu et al., 2007). The shotmu-
tant is, to our knowledge, the first manipulation that activatesWal-
lenda/DLK signaling in Drosophila without altering the levels of
Wallenda/DLK.Hence, loss of shotmust activateWallenda/DLKvia
a novel mechanism. We hypothesize that this mechanism is related
to the biochemical function of Shot, which is to stabilize the cyto-
skeleton by simultaneously binding both actin and microtubules.
Prior studies demonstrate that shot null mutants have a destabilized
microtubule network (Alves-Silva et al., 2012), and we demonstrate
Figure7. shotmutants haveenhancedaxonal sproutingafter injury. Axons are labeledbydrivingexpressionofUAS-mCD8-GFPbym12-Gal4. Axons from(A)WTanimals donot yet formextensive
newbranches by 7h after injury,whereas in shotvv/shot3 (shot)mutants a large growth conewithmultiple sprouting sites canbe seenmore frequently than inWT ( p0.001, 2 test,n30 axons
for each genotype). The number of blunt versus sprouting axonal stumps was counted, and their frequencies are presented in B. C, Same analysis was done on UAS-dcr2;; UAS-mCD8-GFP,
m12-Gal4/ (control), UAS-dcr2; UAS-mCD8-GFP, m12-Gal4/UAS-shot-RNAi; (shot RNAi), UAS-dcr2; UAS-wnd-RNAi/;UAS-mCD8-GFP, m12-Gal4/ (wnd RNAi), and UAS-dcr2; UAS-wnd-RNAi
/UAS-mCD8-GFP,m12-Gal4; UAS-shot-RNAi/ (shot RNAi;wnd RNAi) and quantified in D. n 50 axons for each genotype. Scale bar, 25m.
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that themicrotubule network ismore dynamic in shotRNAi knock-
down larvae. We propose that a destabilized cytoskeleton activates
Wallenda/DLK.Consistentwith thismodel,we showthatmutations
in either of two subunits of the TCP-1 complex, which like Shot
regulates both the actin andmicrotubule cytoskeleton, leads to acti-
vation of DLK signaling. By demonstrating this activation of DLK
signaling, our results support and extend the work of Bounoutas et
al. (2011) who demonstrated that microtubule disruption leads to
DLK-dependent changes in protein levels in C. elegans. Moreover,
our findings are consistent with studies in mammalian cell culture
demonstrating that drugs that destabilize microtubules can activate
MAPkinase signaling(Wangetal., 1998;StoneandChambers,2000;
Yang et al., 2007), as well as studies in Drosophila showing that ge-
neticdisruptionof thecytoskeletoncanactivate JNKsignaling (Mas-
saro et al., 2009).
Axonal injury as a result of trauma or neurotoxic insults, such
as chemotherapy drug treatment, is accompanied by a change in
microtubule network stability. We propose a model in which
DLK functions as a sensor of microtubule network stability.
When the cytoskeleton is destabilized as a result of injury, DLK
will be activated. The consequence of that activation will depend
on downstream signaling pathways and may differ by cellular
compartment. For example, DLK in the distal axon will promote
axonal degeneration (Miller et al., 2009), whereas DLK activation
in proximal axons will facilitate the retrograde transport of injury
signals that can activate regenerative and/or apoptotic gene ex-
pression programs (Shin et al., 2012; Watkins et al., 2013).
Promoting regeneration by activating DLK
In the mammalian PNS, DLK is required for the preconditioning
response that boosts the efficacy of peripheral DRG axon regenera-
tion after a prior nerve injury (Shin et al., 2012). In bothworms and
flies, activation of DLK by increasing its abundance improves the
regenerative response in the absence of a prior nerve injury (Ham-
marlund et al., 2009; Xiong et al., 2010). Hence, it is attractive to
speculate that activation of DLK in the absence of injury may also
improve regeneration in mammalian axons. Our findings with shot
suggest that relatively mild disruptions to the axonal cytoskeleton
can activate DLK and accelerate the regenerative response in Dro-
sophila in the absence of a prior trauma. Future studies will test
whether pharmacological agents that disrupt the cytoskeleton can
activate DLK in mammalian neurons and whether such activation
promotes axon regeneration.
In conclusion, our study demonstrates that, in the absence of
Shot, Wallenda/DLK signaling is activated resulting in synaptic
terminal overgrowth andmore rapid regenerative axonal sprout-
ing. The role of Shot as an actin-microtubule cross-linker sug-
gests that Wallenda/DLK is activated by cytoskeletal disruption
and suggests novel approaches for controlling DLK activity in the
injured or diseased nervous system.
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